Your browser doesn't support javascript.
loading
Measuring the performance of prediction models to personalize treatment choice.
Efthimiou, Orestis; Hoogland, Jeroen; Debray, Thomas P A; Seo, Michael; Furukawa, Toshiaki A; Egger, Matthias; White, Ian R.
Affiliation
  • Efthimiou O; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
  • Hoogland J; Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
  • Debray TPA; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Seo M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Furukawa TA; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Egger M; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • White IR; Smart Data Analysis and Statistics B.V., Utrecht, The Netherlands.
Stat Med ; 42(8): 1188-1206, 2023 04 15.
Article in En | MEDLINE | ID: mdl-36700492
ABSTRACT
When data are available from individual patients receiving either a treatment or a control intervention in a randomized trial, various statistical and machine learning methods can be used to develop models for predicting future outcomes under the two conditions, and thus to predict treatment effect at the patient level. These predictions can subsequently guide personalized treatment choices. Although several methods for validating prediction models are available, little attention has been given to measuring the performance of predictions of personalized treatment effect. In this article, we propose a range of measures that can be used to this end. We start by defining two dimensions of model accuracy for treatment effects, for a single

outcome:

discrimination for benefit and calibration for benefit. We then amalgamate these two dimensions into an additional concept, decision accuracy, which quantifies the model's ability to identify patients for whom the benefit from treatment exceeds a given threshold. Subsequently, we propose a series of performance measures related to these dimensions and discuss estimating procedures, focusing on randomized data. Our methods are applicable for continuous or binary outcomes, for any type of prediction model, as long as it uses baseline covariates to predict outcomes under treatment and control. We illustrate all methods using two simulated datasets and a real dataset from a trial in depression. We implement all methods in the R package predieval. Results suggest that the proposed measures can be useful in evaluating and comparing the performance of competing models in predicting individualized treatment effect.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Models, Statistical / Precision Medicine Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Stat Med Year: 2023 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Models, Statistical / Precision Medicine Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Stat Med Year: 2023 Type: Article Affiliation country: Switzerland